NCT06115538View on ClinicalTrials.gov

Comparison of Dopamin Level in Idiopathic Parkinson's Patients

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

April 30, 2025

Conditions
Parkinson DiseaseTreatment Adherence
Interventions
OTHER

Levodopa

Levodopa benserazide (100+25 mg) will be given to one group of study patients, and levodopa carbidopa entacapone (100+25+200 mg) will be given to the other group of study patients. Just before the drugs are given (0th minute), at 90 and 180 minutes after the drugs are given, a total of 3 doses will be given.

Trial Locations (1)

063000

Ankara Atatürk Sanatorium Training and Research Hospital, Ankara

All Listed Sponsors
lead

Ankara Ataturk Sanatorium Training and Research Hospital

OTHER_GOV